InsidersTradesSigma
Follow the Sino Biopharmaceutical Ltd. stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Sino Biopharmaceutical Ltd. has recorded 6 public disclosures. Market capitalisation: €91.5bn. The latest transaction was filed on 30 April 2026 (Purchase). Among the most active insiders: Cheng Cheung Ling. Every trade is free.
6
Insider Decl.
n/a
Thresholds
€8m
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sino Biopharmaceutical Ltd. Strong Buy (bullish), based on 20 analysts. Average price target: HK$8.28.
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,657 of 29,064 companies
61.6
score / 100
Value53
Quality70
FCF yld7.4%
Earn yld2.3%
EV/EBITDA14.1x
ROE14%
Gross mgn82%
Net mgn7.4%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 April 2026
Declarations6 total
1,000,000 shares@ HK$5.4410.0059% mcap20.0% of flowShareXHKGHKEX:DA20260430E00374
1,000,000 shares@ HK$5.47050.0060% mcap20.2% of flowShareXHKGHKEX:DA20260429E00338
3,000,000 shares@ HK$5.42820.018% mcap59.9% of flowShareXHKGHKEX:DA20260428E00209
1,748,000 shares@ HK$5.730.0012% mcap100.0% of flowShareXHKGHKEX:DA20260330E00223
6 of 6 declarations
关于 Sino Biopharmaceutical Ltd.
Sino Biopharmaceutical Ltd. 是一家在中国从事药品研发和制造的公司。它主要专注于肝病和心血管疾病的治疗药物。